Two COVID-19 antibody therapies are no longer recommended by the World Health Organization (WHO), on the basis that Omicron and the variant's latest offshoots have likely rendered them obsolete. www.reuters.com/business/healthcare-pharmaceuticals/who-strongly-advises-against-use-two-covid-treatments-2022-09-15/? The two therapies - which are designed to work by...

Indian authorities have suspended the licence of Delhi-based drugmaker, Maiden Pharma, after it failed to furnish information on cough syrup related deaths in West Africa’s The Gambia.The company is accused of supplying cough syrup that led to the deaths...